Target Details
| UniProt AC | P15056 |
|---|---|
| Gene Symbol | BRAF |
| Protein Name | Serine/threonine-protein kinase B-raf |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,643
- Clinical molecules 78
- Avg pChEMBL 7.81
KEGG Pathways (44)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Bladder cancer
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemokine signaling pathway
- Chronic myeloid leukemia
- Colorectal cancer
- Cushing syndrome
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Insulin signaling pathway
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanoma
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Progesterone-mediated oocyte maturation
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Renal cell carcinoma
- Serotonergic synapse
- Thyroid cancer
- Vascular smooth muscle contraction
- cAMP signaling pathway
- mTOR signaling pathway
Associated Diseases (10)
Active Molecules (2,643)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
QVCPOQFCEWSFDK
|
9.1 | IC50 | 2 | — | |
RSTXFOXHTPABQN
|
9.1 | IC50 | 2 | — | |
SBBUFHIBOBVZBO
|
9.1 | IC50 | 2 | — | |
UEFADVPYCZXKGV
|
9.1 | IC50 | 2 | — | |
UEPHFBVVASDYFP
|
9.1 | IC50 | 2 | — | |
VIMSPEXOOOZTHP
|
9.1 | IC50 | 2 | — | |
WCGIFAUOSCNXHI
|
9.1 | IC50 | 2 | — | |
WOERSGXKJYKTFB
|
9.1 | IC50 | 2 | — | |
XEYZNMHSYXXOIB
|
9.1 | IC50 | 2 | — | |
XQJXMKDWOQZRNQ
|
9.1 | IC50 | 2 | — | |
ZEDGADXCYUSDJB
|
9.1 | IC50 | 2 | — | |
ZZVJHMMNODGNHU
|
9.1 | IC50 | 2 | — | |
GWGGUTZJIZNMNO
|
9.1 | IC50 | 2 | — | |
JCQCZVGYVYKECZ
|
9.1 | IC50 | 2 | — | |
QDHRVJSENVYTRB
|
9.1 | IC50 | 2 | — | |
TYRBFDFCWLLXCF
|
9.1 | IC50 | 2 | — | |
ZGUMGEWKRSSPDW
|
9.1 | IC50 | 2 | — | |
AQEDEXWKMRFNFJ
|
9.1 | IC50 | 2 | — | |
FRGRAXZJOUXYJI
|
9.1 | IC50 | 2 | — | |
NAKWVFQLIVIFBL
|
9.1 | IC50 | 2 | — | |
POLYTOCMNSPOHH
|
9.1 | IC50 | 2 | — | |
UEPXBTCUIIGYCY
|
9.1 | IC50 | 6 | — | |
UYOJMJVLQBMLJD
|
9.1 | IC50 | 3 | — | |
ZUXPFTYMSHPRQX
|
9.1 | Kd | 2 | — | |
NBZGAVIGFGPZPW
|
9.1 | IC50 | 2 | — | |
VATRAMGKPXJFAV
|
9.1 | IC50 | 3 | — | |
BDMRXFODCGLAFM
|
9.1 | IC50 | 2 | — | |
CTNPMQXPGPPUPD
|
9.1 | IC50 | 2 | — | |
CTUGLUQSZFLOBO
|
9.1 | IC50 | 2 | — | |
FTKQZJLHOBVYDM
|
9.1 | IC50 | 2 | — | |
GDKAQFPZKOUPJE
|
9.1 | IC50 | 2 | — | |
HWUXFYYLSPICMG
|
9.1 | IC50 | 2 | — | |
KRNDDDCYLBZERO
|
9.1 | IC50 | 2 | — | |
LSLALUAEWYZHTB
|
9.1 | IC50 | 2 | — | |
OBNSXLCGQZZEPT
|
9.1 | IC50 | 2 | — | |
PEMGBJKQLVWMRD
|
9.1 | IC50 | 2 | — | |
QCXLSMOFUZBIOO
|
9.1 | IC50 | 2 | — | |
RDRRLTKYMVDKDE
|
9.1 | IC50 | 5 | — | |
UUTYQXMHXSFYES
|
9.1 | IC50 | 2 | — | |
VPFGZMRBOWQVQS
|
9.1 | IC50 | 2 | — | |
XHHNLTAZMYOOSD
|
9.1 | IC50 | 2 | — | |
XSVKRHSFWQKQDN
|
9.1 | IC50 | 2 | — | |
ZUTBFIUGERXPPP
|
9.1 | IC50 | 2 | — | |
CYQSREZKCOHNRE
|
9.0 | IC50 | 2 | — | |
HVTUZZBOLLPTQC
|
9.0 | IC50 | 2 | — | |
MJJHTBWDJAMARJ
|
9.0 | IC50 | 2 | — | |
HZGBRTKLYANMLH
|
9.0 | IC50 | 2 | — | |
LFYPPNJBUXJRMO
|
9.0 | IC50 | 3 | — | |
SWTUEFNNTINTDY
|
9.0 | IC50 | 2 | — | |
APTZOLCMZQNBAH
|
9.0 | IC50 | 2 | — |